Stockreport

Dr. Reddy's (RDY), Kainomyx Sign Potential Deal for Malaria Drug [Yahoo! Finance]

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors
PDF anti-malarial drug in the United States, EU and low and middle-income countries. Kainomyx is a U.S.-based company that utilizes its proprietary platform to develop candi [Read more]